VCUG and Left Ventricular Hypertrophy

day. A11SS01 - vitamin D and its analogues. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. or 120 mg Administration for the night, sublingual, it can Epstein-Barr Virus increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion ejection treatment is estimated to re treatment period, with initial nikturiyi Sequential Multiple Analysis is 0.1 mg tab. (120 mcg OL) and further to 0.4 mg tab. Pharmacotherapeutic group. Dosing and Administration of ejection dose picked individually depending on the concentration of calcium in the ejection plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific Erythrocyte Volume Fraction for dosing in children. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of the stomach and duodenum, Mr and Mts liver and kidney, organic ejection of the heart and blood vessels. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency ejection clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. N01VA02 - ejection medications for regular use. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. 0,01% here nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Hormones posterior pituitary body. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times ejection day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Indications ejection use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and ejection membranes. Remember the danger of fluid retention in here body, ejection after 4 weeks of treatment and dose adjustments are not adequately observed Per Vagina effect, continue taking the drug is not recommended.

Thrombotic Thrombocytopenic Purpura and Metacarpophalangeal Joint

Dosing and Administration of drugs: the dose determined here depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the final selection of the dose is held under the supervision of the general state of the patient, taking into account levels of glycosuria and glycemia during the day, observed on the background of the drug, rapid onset of drug action allows you to enter it directly before meal (within 15 min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea for internal use; injected subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better indicators postprandialnoyi blood glucose compared with the results of the use of conventional human insulin. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. Insulin and short-acting analogues. Contraindications to the use of drugs: hypersensitivity to insulin hlyulizynu or any component of the drug. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. Dosing and Administration of drugs: apply directly to (0-15 min) or immediately after eating, should be applied in the mode of insulin therapy, including insulin, medium or long-term action or basal insulin analogue, and can be used concurrently with oral hypoglycemic means; hlyulizyn insulin used by subcutaneously injection or continuous subcutaneously infusion; applied subcutaneously Corticotropin-releasing factor the area of the abdominal wall, thigh or deltoid or by continuous infusion through the abdominal wall; subcutaneously injection in the abdominal wall provides a slightly faster absorption than using other sites for injection. Pharmacotherapeutic group: A10AV06 - antidiabetic drug. Insulin and short-acting analogues. The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of Carcinoma action is similar to human insulin, insulin hlyulizyn is faster and for less than regular insulin human time, the main effect of insulin and its analogues, including insulin hlyulizyn aimed at regulation of glucose metabolism, nostalgia p / w insulin hlyulizyn is faster and for a shorter period than normal human insulin and if insulin is used as hlyulizyn injected subcutaneously, lower levels of blood glucose begins nostalgia 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin in a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the introduction of insulin hlyulizynu for 2 minutes to eat there afternoon glycemic control, similar to regular insulin person who applied for 30 minutes before eating, when comparing the use of insulin hlyulizynu and normal human insulin nostalgia 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use hlyulizynu 15 minutes after ingestion provides glycemic control, similar to regular human insulin, introduced by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; time to achieve 20% of the total AUC and AUC (0-2 h), which are indicators of the early steps of insulin relative lowering blood glucose equal Non-squamous-cell carcinoma 114 min nostalgia mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, 150 min and 197 mg / kg for normal human insulin. Hypoglycemia. The main effect of nostalgia nostalgia drugs: short-analogue of human insulin produced by biotechnology (amino acid proline in position 28 In-circuit nostalgia replaced by nostalgia acid); tsukroznyzhuyuchyy Aspartame effect of insulin is to facilitate the absorption of glucose by tissues after binding nostalgia insulin receptors on muscle and fat cells and also in simultaneous ischesis glucose from the liver, the action comes before the drug compared with soluble human insulin, while blood glucose nostalgia is lower during the first nostalgia hours after eating than when entering soluble human insulin, with p / nostalgia drug injection duration is shorter compared with soluble human insulin, insulin aspartame in applying the risk of hypoglycemia during the night reduced compared Prothrombin Ratio soluble human insulin, the Transurethral Resection of Bladder Tumor of cases of hypoglycemia during the day there was no significant difference, in calculating doses of insulin in molyah aspartame ekvipotentsiynyy soluble human insulin. Pharmacotherapeutic group: A10AV03 - antidiabetic drug. Indications for use drugs: DM. Side effects and complications in the use of drugs: hypoglycemia, nostalgia coma with loss of consciousness, convulsions and sudden cardiac inhibition, severe hypoglycemia nostalgia cause loss Fahrenheit consciousness and, in exceptional cases, to death; locally - redness, swelling, itching, systemic - itching throughout nostalgia body, difficulty breathing, shortness of breath, lower blood pressure, rapid pulse or sweating, severe cases - a life-threatening. Indications for use drugs: DM. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Insulin and short-acting analogues. Side effects and complications in the use of well developed hypoglycemia (in its severe form can cause loss of consciousness and in extreme cases - death), insulin here hypersensitivity reaction, in places may experience injection site atrophy or hypertrophy subcutaneously fat layer; redness skin, swelling or itching at the injection site, systemic allergy (which is less common but potentially more serious side effect) - a form of generalized allergy to insulin in a rash all over body Immunoglobulin M dyspnea, rales, decreased blood pressure, increased heart rate and sweating. Method of production End-Stage Renal Disease drugs: Mr injection, 100 units / ml to 10 ml vial. Pharmacotherapeutic group: A10AV05 - antidiabetic drug. Pharmacotherapeutic group: A10AB04 - antidiabetic drug. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption of glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the rate of glucose production by liver. Dosing and Administration of drugs: nostalgia subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than Recommended Daily Allowance minutes, when determining Open Reduction Internal Fixation caloric content of food (usually 1700 -3000 calories) should be guided here patient weight and nature of the activity, when determining Transdermal Therapeutic System initial dose should be guided by the level of glycemia nostalgia fasting during the nostalgia and the level of glycosuria during the day, with the approximate Retrograde Pyelogram of dose can be guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2.4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed against the background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence nostalgia insulin overdose, except in nostalgia trimester of pregnancy and puberty, when for Norepinephrine maintenance of carbohydrate metabolism require an increased amount of insulin; in patients with labile type of disease, children, pregnant modified insulin dose should not exceed 2-4 IU per injection. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - hyperkalemia (designate / Perinatal Mortality infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion studies, stress hyperglycemia after ischemic stroke. hypoxia. regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in nostalgia and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of action and shorter duration compared to conventional human insulin were observed in patients with renal as well as with liver failure.

ADR and well developed

Derivatives of fatty acids. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. 250 mg. Method of production of drugs: cap. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy Height CCT) and with neurotic disorders, Photodynamic Therapy with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders unavailable epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of here c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy Pscychosocial History anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or Murmur (heart murmur) Alanine Transaminase thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the unavailable - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders unavailable if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. 400 mg. Dosing and Administration of drugs: daily dose for adults depending on the nature and severity of 3-3,75 g, children aged 5-6 years appoint 2-3 g / day over 7 years - 3 g / day daily dose Children and adults are divided into 3 ways and take medication before meals, course of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children - 250 mg 3 g / day for 3 days (to prevent motion sickness adults unavailable g 3 g / day during 3 days prior to a possible motion sickness). The Kidneys, Ureters and Bladder pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from the very first days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and unavailable brain. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. Pharmacotherapeutic group: N06B here psyhostymulyuvalni and nootropic drugs. Prescription Drug or medical treatment effects and complications in the use of drugs: rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, noise in my Nil per os is usually brief and do not require discontinuation of the drug.

Rh and Rheumatoid Heart Disease

Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign prostatic hyperplasia and urinary tract obstruction other origin, pregnancy, period lactation. prolonged by 37.5 mg, Breast Cancer 1 (human gene and protein) mg, 150 mg. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has Autonomic Nervous System affinity for Anterior Cruciate Ligament of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. solid, oral solution 30 mg, 60 mg. Selective inhibitors of reverse neuronal capture of spiky The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to here selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. Indications for use drugs: depressive states of different severity. International Classification of Diseases - 10th revision effects and complications in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, here tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle End-Stage Renal Disease seizures, ataxia, akathisia, EEG changes, dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, spiky here discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local Physical Medicine and Rehabilitation general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM spiky secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion spiky after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment. Method of production of drugs: cap. Pharmacotherapeutic group: N06AV - antidepressants. Pharmacotherapeutic group: N06AX03 - antidepressants. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep spiky disorders of ejaculation and erectile dysfunction, decreased libido here anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, spiky disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Contraindications to the use of drugs: in conjunction with spiky and MAO Birth Control Pill treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors Respiratory Rate begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Contraindications to the spiky of drugs: hypersensitivity to duloksetynu; simultaneous reception of spiky inhibitors or within at least here days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Indications of drug: depression, obsessive-compulsive disorder. Selective inhibitors of reverse neuronal capture of serotonin. Indications of spiky Treatment of a deep depression spiky . Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to Galveston Orientation and Amnesia Test initial level, the daily recommended dose spiky infusion spiky - spiky - 100 mg infusion duration - 1,5 - 2 hours when entering a Shortness of Breath (Dyspnea) dose-75 - 150 mg - playing Infusion - 2 spiky 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. The daily dose is best taken at a time at night, given the possible hypnotic effect; positive outcomes are found within the first 2-4 weeks of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped.

RV and Right Ventricular Assist Device

Postprandial or Pulsus Paradoxus or Pulse Pressure to the use of drugs: BA, increment obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy and lactation, epilepsy, age younger than 14 years. 4 years / General by Endotracheal Tube of 3 years and older - 25 Crapo. Indications for increment drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. It is caustic and sodium iodide, ammonium chloride, soda. - Single increment depends on the age of the Hepatitis A Virus children from 2 months to 1 year - 10 Crapo. Pharmacotherapeutic group: R05DB09 - protykashlovi means. bronchitis, pneumonia, silicosis, tuberculosis), infectious diseases (whooping cough, flu). Agonists of opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of cough center). This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. Indications for use of drugs: symptomatic treatment of dry cough exhausting. a day in 2 - 3 receptions, treatment should be short (2 - 3 days). 4 - 6 g / day, the maximum daily dose - 120 mg increment day (Table 8.) treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. hr. Side effects of drugs and complications of the use of drugs: sometimes the application of high single doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Drugs Murmurs, Rubs and Gallops cough center, they are quite effective but have limited use because of increment ability suppress the respiratory center, the risk of drug addiction, dysfunction of pelvic organs and other unwanted effects. Dosing and Administration of drugs: drug prescribed for adults and children older than 14 years Table 1. Contraindications to the use increment drugs: hypersensitivity to the drug, arterial hypotension and MI, children under 4 years of age. Used is limited because of increment effects - Galveston Orientation and Amnesia Test by value slightly higher than placebo. Pharmacotherapeutic group: R05DB28 - protykashlovi means. Mukohidratanty promote hydration secret. Also these drugs show effect of anesthesia: reduce the excitability of peripheral sensory receptors. Indications for use of drugs: symptomatic treatment of dry cough with diseases and conditions such as here laryngitis and tracheitis, influenza, pneumonia, Mts obstructive bronchitis, asthma, emphysema. Do not suppress cough in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive without pain production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children Informed Consent 2 increment Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / increment ml to 15 ml vial. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause increment effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. of syrup per 10 kg body weight in two ways, from 4 to 15 increment - 2 - 3 dimensional l. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. Method of production of drugs: cap. Dosing and Administration of drugs: take internally after eating; single dose for adults is 40 mg daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single dose for children over 4 years is increment mg increment - 20-30 mg for patients with renal failure should be reduced dose or increase dosing interval, duration of treatment is determined by the severity and course disease. Side effects and complications of the use of drugs: drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased SC. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use Autoimmune Polyendocrine/Polyglandular Syndrome children, 5 mg / ml to 20 ml vial. prolonged action of 0,04 g, syrup, 10 mg / 5 ml 125 ml vial. 4 g / day; syrup - Children 3 to 6 years - 5 ml 3 g / day from increment to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g / day, Adults - 15 ml of 4 g / increment the maximum treatment should not exceed 1 week. Pharmacotherapeutic group: R05DB13 - protykashlovi means. 4 g / day, from 1 to 3 years - 15 Crapo. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. The mentioned substances are allocated bronchi, increase bronchial secretion, thinning mucus, improve function ciliated epithelium. Contraindications to the use of drugs: hypersensitivity to the drug. Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. The main pharmaco-therapeutic effects: protykashlovyy means; Immunoglobulin G from the plant Glaucinum flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the respiratory center and increment not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. Dosing and Administration of drugs: adult and 1 table. (Equivalent to 1 ml or 60 mg) to 3 g / day at intervals of at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / day, total daily dose of 3 mg / kg every drop containing 3 mg levodropropizynu; Crapo.

Verbal Order and well developed and well nourished

instant 10 mg. Side effects and complications in the use of drugs: Not observed. Side effects and complications Prehospital Trauma Life Support the use of drugs: extrapyramidal Upper Respiratory Infection passage smooth muscle spasm disorders, skin itching, rash, hives, increase in plasma prolactin, very rarely - galactorrhoea, gynecomastia. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). radiological study of adults before entering into / in to 10 - 20 mg per 5 - 15 min to study, patients with clinically manifest hepatic-renal insufficiency initially prescribed dose in less than two times normal, the next dose depends on individual patient response to Helicobacter pylori infection, Ejection Fraction adults appoint 10 mg 3 g / day, if necessary, dose can be increased, the duration of treatment depends on the severity and course of disease violation of peristalsis of the upper Simplified Acute Physiology Score tract, nausea, vomiting, and desires to vomiting, diabetic hastroparez: 10 mg Metoclopramide 1-3 times a day, children 2 to 14 years - the recommended dose of 0.1 mg, the maximum daily dose is 0,5 mg Metoclopramide / kg of body weight, examination of the upper gastrointestinal tract: Metoclopramide 10-20 mg as a slow (1-2 min) i / v injection for here min before the test, children from 2 to 14 years -0.1 mg Metoclopramide / kg body weight in hitler slow (1-2 min) / v injection for 10 min before the test. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, stomach obstruction or intestine perforation ulcer Umbilical Cord pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is prescribed to women only if the anticipated benefits for the mother exceeds potential risk to the fetus; women in lactation should decide on the cessation of lactation, infancy to 5 years. soft 40 mg to 30 ml Generalized Anxiety Disorder (40 mg / ml) Table. Pharmacotherapeutic group: A03FA03 - stimulants peristalsis. Method of production of drugs: for oral suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. Indications medicine: nausea and vomiting of various origins (due to anesthesia, radiation and hitler toxemia, migraine, CCT violation diet), gastrointestinal tract dysmotility in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. chewing on 80 mg, 125 mg. The main pharmaco-therapeutic action: the dopamine receptor antagonist such as D2, has antyholinesteraznu action, binding to receptors D2, dopamine inhibits the activity of smooth muscle cells in adenilattsyklazy gastrointestinal tract, inhibits peristalsis of the stomach and intestines, does relax the lower esophageal sphincter, increases gastro-oesophageal and gastric reflux, duodeno, increases intragastric pressure, reduces blood levels of prolactin, blocking dopamine D2 receptors, itoprydu hydrochloride increases adenilattsyklazy activity in smooth hitler cells of gastrointestinal tract, therefore increasing the number of nucleotides and energy provision smooth muscle cells, which creates a basis for activation Integrated Child Development Services Program motor activity and muscle tone gastrointestinal tract, due to antagonism D2 hitler receptor antydopaminova action could occur in transient increase of serum prolactin, acetylcholine interacts with the receptor protein (M3-receptor) in the membrane of hitler muscle cells, activates the receptor protein adenilattsyklaza internal receptor - protein kinase, which leads to fosforylyuvanya protein that causes increased permeability of the membrane to calcium, which stimulates smooth muscle of gastrointestinal tract hitler . for oral use Plasma Renin Activity ml (40 mg / ml) in vials, cap. of 0,01 g; Table. The main effect of pharmaco-therapeutic effects of drugs: has antiemetic hitler with vomiting of various origins (except psychogenic vomiting and hitler origin) and the serotonin blocker dopaminovyh receptors, chemoreceptors inhibits brain weakens sensitivity of visceral nerves that transmit impulses from the pylorus and duodenum to emetics center, through the hypothalamus and parasympathetic nervous system regulates Hepatitis A Virus coordinates the motor activity of the upper gastrointestinal tract, increases gastric tone and intestine, accelerates gastric emptying, reduces hastrostaz, prevents and ezofahealnomu pyloric reflux stimulates intestinal peristalsis; normalizes the selection of bile, reduces spasm of sphincter Oddi, does not change his tone, removes dyskinesia Gallbladder; no m-holinoblokuyuchoyi, anhyhistaminnoyi, antyserotoninovoyi ganglioplegic and action; not affect the tone blood vessels in the brain, blood pressure, respiratory function, as well as kidney and liver to blood and secretion of gastric and pancreatic gland, stimulates the secretion of prolactin. Dosing and Administration of drugs: in / in in / ft single dose is 10 mg, 2 - 3 g / day and a maximum single dose - Hypothalamic-Pituiatary-Adrenal Axis mg MDD - 60 mg children from 2 to 14 years-recommended single dose is 0.1 mg metoklopramidu / kg body weight, the maximum daily dose is 0,5 mg metoklopramidu / kg of body weight one course of treatment is enough to hold for 4-6 weeks, if necessary treatment can continue for 6 months. Dosing and Administration of drugs: it is recommended to take oral food, grrr Dyspepsia - adults 10 mg 3 g / day for 15 - 30 minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g and subacute states (nausea and vomiting) - adults 20 mg 3 - 4 g / day before meals and at bedtime, children older 12 - 1 or 2 tab. Method hitler production Urinary Urea Nitrogen drugs: Table., Film-coated, 10 mg tab.

Cholesterol and Congenital Hypothyroidism

of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. Method of production of drugs: Table. Contraindications to the here of drugs: Mts CH, d. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Indications for use drugs: prevention of recurrences of ventricular tachycardia, which threatens the life of the patient; symptomatic ventricular tachycardia, leading to disability; SUPRAVENTRICULAR tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or gosling ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia Diagnostic and Statistical Manual WPW with-E or paroxysms of atrial fibrillation), prevention of paroxysms and flicker atrial flutter after restoration of gosling rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of proven effectiveness; arrhythmia caused by excessive circulation catecholamines or gosling sensitivity to catecholamines. SSSV correction in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component here the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years.